Conference abstractPublished 2 Aug 2017
Genomic Drivers of Human Cancers: Diagnostics, Prognostics and therapeutics
Department of Pathology, University of Pittsburgh School of Medicine, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Accurate prediction of clinical courses of human cancers remains elusive. In recent studies, we performed whole genome analysis on prostate and liver cancers. Our result showed that combination of genome copy number variance and novel fusion transcripts specific for cancer achieved high accuracy in predicting clinical outcomes of these cancers. Interestingly, some of these fusion genes are also present in a variety of human malignancies. Some of these fusion gene products trigger new pathways that are essential for carcinogenesis in multiple human cancers, and create novel functions that are not present in wild type gene counterparts. Treatment of cancers with drugs specific for fusion genes and their signaling pathways produced dramatic improvement of metastasis and survival rate of animals xenografted with cancers positive for these fusion genes. Our analyses suggest that targeting therapy for fusion genes holds promise as an effective treatment for human cancers.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGenetics & Molecular Biology
- SubjectOncology & Cancer
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Jianhua Luo”